UnitedHealth Group Incorporated (UNH) is preparing to release its third-quarter 2026 earnings on October 13, 2026, before the market opens. Analysts expect earnings of $4.12 per share on revenues of $111.38 billion. While earnings are projected to rise 41.1% year-over-year, revenues are anticipated to decline 1.6%. For the full year, revenues are expected to drop 0.2%, but earnings per share should increase 21.4%.
UnitedHealth has surpassed earnings estimates in each of the last four quarters, with an average surprise of 12.1%. However, current indicators suggest a possible deviation from this trend, as the company’s Earnings ESP stands at 0.00% with a Zacks Rank of 2 (Buy). The decline in premium revenues, driven by reduced contributions from UnitedHealthcare and Optum Health, is expected to impact results. Membership declines in Medicare Advantage and Medicaid are also contributing factors.
Despite these challenges, improved medical cost management may offset some negative effects, with the medical care ratio estimated at 90.1%. Operating income from UnitedHealthcare and Optum is projected to rise significantly. UnitedHealth’s stock has gained 13.9% year-to-date, lagging behind industry peers and the S&P 500. The company’s valuation, at 17.15X forward earnings, is below its five-year median but above the industry average.
Management’s focus on strategic portfolio optimization and cost management positions UnitedHealth for gradual recovery. However, membership declines and high healthcare utilization remain concerns. The upcoming earnings report will be critical in assessing the sustainability of recent operational improvements.